€18.80
2.91% today
L&S, Jul 02, 07:19 pm CET
ISIN
US09062W2044
Symbol
BLFS

BioLife Solutions, Inc. Target price 2024 - Analyst rating & recommendation

BioLife Solutions, Inc. Classifications & Recommendation:

Buy
100%

BioLife Solutions, Inc. Target price

Target price $24.78
Course $20.79
Price potential
Number of estimates 9
9 Analysts have issued a price target BioLife Solutions, Inc. 2025 . The average BioLife Solutions, Inc. target price is $24.78. This is higher than the current share price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 9 Analysts recommend BioLife Solutions, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the BioLife Solutions, Inc. share has an average upside potential 2025 of . Most analysts recommend the BioLife Solutions, Inc. share at Purchase.

Sales and margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million $ 143.27 107.92
11.43% 24.67%
EBITDA margin -31.58% 10.65%
155.90% 133.73%
Net margin -48.47% -23.13%
47.84% 52.28%

9 Analysts have issued a sales forecast BioLife Solutions, Inc. 2024 . The average BioLife Solutions, Inc. sales estimate is

$108m
Unlock
. This is
21.40% lower
Unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
$120m 12.53%
Unlock
, the lowest is
$100m 27.17%
Unlock
.

This results in the following potential growth figures:

Sales forecast

2023 $143m 11.43%
2024
$108m 24.67%
Unlock
2025
$122m 12.58%
Unlock
2026
$150m 23.49%
Unlock
2027
$227m 51.33%
Unlock
2028
$289m 27.23%
Unlock

5 Analysts have issued an BioLife Solutions, Inc. EBITDA forecast 2024. The average BioLife Solutions, Inc. EBITDA estimate is

$11.5m
Unlock
. This is
126.68% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$12.4m 128.79%
Unlock
, the lowest is
$10.5m 124.30%
Unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 $-45.2m 126.65%
2024
$11.5m 125.40%
Unlock
2025
$21.4m 86.30%
Unlock
2026
$32.6m 52.25%
Unlock

EBITDA margin

2023 -31.58% 155.90%
2024
10.65% 133.73%
Unlock
2025
17.62% 65.45%
Unlock
2026
21.73% 23.33%
Unlock

8 BioLife Solutions, Inc. Analysts have issued a net profit forecast 2024. The average BioLife Solutions, Inc. net profit estimate is

$-25.0m
Unlock
. This is
61.80% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-20.1m 69.24%
Unlock
, the lowest is
$-33.8m 48.25%
Unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 $-69.4m 53.80%
2024
$-25.0m 64.06%
Unlock
2025
$-14.8m 40.91%
Unlock
2026
$5.7m 138.71%
Unlock
2027
$51.2m 796.15%
Unlock
2028
$90.9m 77.68%
Unlock

Net margin

2023 -48.47% 47.84%
2024
-23.13% 52.28%
Unlock
2025
-12.14% 47.51%
Unlock
2026
3.81% 131.38%
Unlock
2027
22.54% 491.60%
Unlock
2028
31.47% 39.62%
Unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share $ -1.52 -0.55
53.80% 63.82%
P/E ratio negative
EV/Sales 8.83

8 Analysts have issued a BioLife Solutions, Inc. forecast for earnings per share. The average BioLife Solutions, Inc. <a href=/blog/eps>EPS is

$-0.55
Unlock
. This is
61.54% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
$-0.44 69.23%
Unlock
, the lowest is
$-0.74 48.25%
Unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 $-1.52 53.80%
2024
$-0.55 63.82%
Unlock
2025
$-0.32 41.82%
Unlock
2026
$0.13 140.63%
Unlock
2027
$1.12 761.54%
Unlock
2028
$1.99 77.68%
Unlock

P/E ratio

Current -14.57 158.33%
2024
-38.06 161.22%
Unlock
2025
-64.39 69.18%
Unlock
2026
166.32 358.30%
Unlock
2027
18.56 88.84%
Unlock
2028
10.45 43.70%
Unlock

Based on analysts' sales estimates for 2024, the BioLife Solutions, Inc. share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 6.94 19.24%
2024
8.83 27.30%
Unlock
2025
7.85 11.18%
Unlock
2026
6.35 19.02%
Unlock
2027
4.20 33.92%
Unlock
2028
3.30 21.40%
Unlock

P/S ratio

Current 6.98 18.49%
2024
8.87 27.22%
Unlock
2025
7.88 11.18%
Unlock
2026
6.38 19.02%
Unlock
2027
4.22 33.92%
Unlock
2028
3.32 21.40%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today